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Summary
BACKGROUND: Plaque vulnerability plays an important
role in determining the risk of subsequent cerebrovascular
events in patients with carotid stenosis. Plaque morpholo-
gy magnetic resonance imaging (MRI) can be used to as-
sess plaque vulnerability. We therefore set out to examine
the diagnostic accuracy of plaque morphology MRI com-
pared with histopathological findings as gold standard in
moderate- to high-grade carotid stenosis at our centre.
METHODS: A total of 36 patients with moderate- to high-
grade carotid stenosis underwent plaque morphology MRI
with a multisequence protocol (time of flight sequence,
dark blood T1- [native and post-gadolinium] and
T2-weighted sequence with fat suppression). The status
of the fibrous cap, calcification, lipid-rich necrotic core
(LRNC) and intraplaque haemorrhage (IPH) were as-
sessed by means of qualitative MR analysis of plaque
characteristics and compared with the histopathological
findings. Detection statistics (sensitivity, specificity), chi-
squared test, Cohen’s kappa (κ), percentage of agreement
and phi coefficient (φ) were determined.
RESULTS: Carotid stenosis was symptomatic (transient
ischaemic attack, amaurosis fugax or ischaemic stroke in
the territory of the stenosed carotid artery) in 25 patients
(69.5%). Twenty-eight patients (77.8%) had a high-grade
and eight patients (12.2%) a moderate-grade stenosis.
Significant congruence between MRI and histology was
found for plaque calcification (89% histology, 75% MRI, κ
= 0.364, p = 0.013), for LRNC (89% histology, 53% MRI, κ
= 0.245, p = 0.025) and IPH (75% histology, 53% MRI, κ
= 0.314, p = 0.035). In a subgroup of patients with symp-
tomatic stenosis, the agreement for LRNC and IPH was
slightly better (LRNC κ = 0.390, p = 0.014; IPH κ = 0.386,
p = 0.045). Status of the fibrous cap, essentially ulcera-
tion, did not show any significant agreement (κ = 0.032, p
= 0.842). There was significant correlation between LRNC
on MRI and symptomatic carotid stenosis (φ = 0.339, p =
0.042).
CONCLUSION: Plaque morphology MRI is capable of
identifying the main components of atherosclerotic
plaques with moderate to good accuracy as compared
with histopathological findings as gold standard. LRNC
seems to be a useful marker of plaque vulnerability and
warrants its use in clinical decision making.
Keywords: carotid plaque morphology, carotid stenosis,
plaque characteristics, vulnerable plaque, high-resolution
magnetic resonance imaging
Introduction
Stroke is the third leading cause of death and the most
common cause of long-term disability [1]. Cerebral em-
bolism from carotid artery plaque due to plaque rupture
is an important pathophysiological mechanism of ipsilater-
al stroke [2]. It is well established that surgical treatment
such as carotid endarterectomy reduces the risk of stroke in
patients with symptomatic high-grade carotid stenosis [3].
The treatment of asymptomatic carotid stenosis is more
controversial. Thus it is crucial to identify patients who
are at risk for carotid artery embolism resulting in ip-
silateral stroke. Traditionally, the degree of stenosis has
been used to assess the risk of thromboembolism from
carotid plaques [4–8]. However, nowadays the importance
of plaque morphology features as an additional factor for
vulnerability is well-accepted [2, 9–11]. Plaque morphol-
ogy components indicating plaque vulnerability are a thin
or disrupted fibrous cap, a large lipid-rich necrotic core
(LRNC), neovascular growth and intraplaque haemorrhage
(IPH) [12, 13], whereas calcification is considered as a
component of plaque stability [14]. Magnetic resonance
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imaging (MRI) has been shown to identify the various
plaques features. In patients at risk for an ipsilateral stroke,
noninvasive imaging techniques, especially MRI, may
play an important role in therapeutic decision making [15].
Although multisequence MRI is already well-established
in the analysis of carotid plaque characteristics, this
method was relatively new at our centre and not yet fre-
quently used as standard procedure to determine patients at
risk of ipsilateral stroke. We therefore set out to define the
diagnostic accuracy of plaque morphology MRI in com-
parison with histopathological findings as gold standard.
Secondarily we compared the subgroups of symptomatic
and asymptomatic patients and also the correlation be-
tween each plaque component and the presence of neuro-
logical symptoms.
Patients and methods
Study population
Patients with symptomatic and asymptomatic high- and
moderate-grade carotid stenosis were included. A sample
size calculation was not performed. Patients were drawn
from the population of a larger study analysing plaque
morphology on MRI and clinical outcome [16]. Patient da-
ta were gathered retrospectively up to April 2015 at In-
selspital, University Hospital of Bern. The cantonal ethics
committee of the canton of Bern approved the study setting
and all patients gave their informed consent.
Study setting and methods
We compared carotid plaque characteristics on 3-Tesla
carotid plaque MRI with histology as gold standard. This
was to analyse the diagnostic accuracy of MRI for as-
sessing the various plaque components compared to
histopathological findings. Secondarily we analysed both
the agreement in detecting plaque criteria between MRI
and histology in subgroups of symptomatic and asymp-
tomatic patients and the correlation between particular
plaque components and the presence of neurological symp-
toms. Inclusion criteria were a preoperative plaque mor-
phology MRI and intraoperative plaque resection for fur-
ther analysis. The decision to perform carotid surgery was
made individually by interdisciplinary consent and was
not in the scope of our study. The degree of stenosis was
determined by duplex ultrasound based on the NASCET
method [3, 17], with high grade stenosis defined as ≥ 70%
and moderate grade 30 to 60% stenosed lumen. A steno-
sis was defined as symptomatic if patients had suffered
from a transient ischaemic attack, amaurosis fugax or an
ischaemic stroke in the territory of the stenosed carotid
artery up to 6 months before inclusion in the study.
MRI protocol
The entire image analysis was done by MLM and MEK as
described previously [16]. They were blinded to the status
of the patient (asymptomatic/symptomatic) and the results
of the histological analysis. Plaques with imaging features
of a thin/disrupted fibrous cap, a large lipid-rich necrotic
core (LRNC) or intraplaque haemorrhage (IPH) were con-
sidered “vulnerable” [12, 13].
The following imaging protocol was used for the evalua-
tion of the carotid plaques:
The carotid artery was imaged using a 3-T MRI system
(Magnetom TrioTim syngo, VB15, Siemens, Erlangen,
Germany) with a four-channel phased array surface coil
(Machnet BV, Eelde, The Netherlands). A coronal se-
quence was used to localise the carotid bifurcation and its
plaque distribution and was followed by an axial 3D mul-
tislab time of flight (ToF) angiography (TR/TE 22/3.86
ms, FOV read 200 mm, FOV phase 83.3%, slice thick-
ness 0.65 mm, averages 1). This was followed by three
pulse-triggered, double inversion recovery, turbo spin echo
dark-blood sequences in order to avoid artefacts from the
inflowing blood: (1) nonfat-saturated T1-weighted images
(WI) (TR/TE 400/ 8.6 ms, 10 slices, slice thickness 3 mm,
FOV read 150 mm, FOV phase 100%, averages 2); (2) fat-
saturated sequence T2WI (TR/TE 700/52.0 ms, 10 slices,
slice thickness 3 mm, FOV read 150 mm, FOV phase
100%, averages 3), and (3) contrast-enhanced (CE) fat-sat-
urated T1WI after intravenous gadolinium (TR/TE 400/
8.6 ms, 10 slices, slice thickness 3 mm, FOV read 150
mm, FOV phase 100%, averages 2). With a zero-filled
Fourier transform applied to all sequences, a voxel size of
0.5 × 0.5 × 3.0 mm was achieved. The carotid bifurca-
tion was used as a landmark for matching the four differ-
ent sequences at each slice location. Plaque components
were characterised according to previously published cri-
teria based on relative tissue signal intensities in compar-
ison with the adjacent sternocleidomastoid. Details of the
criteria were as follows: calcifications were of hypointense
signal intensity in all sequences; the signal intensity of
the lipid-rich necrotic core with IPH depended on the age
of the haemorrhage: IPH type I (fresh) was hyperintense
in ToF and T1WI and hypo-/isointense in T2WI and CE-
T1WI, whereas IPH type II (recent) was hyperintense in
all sequences. The LRNC without IPH was isointense in
ToF, hyperintense in T1WI, of variable intensity on T2WI
and hypointense in CE-T1WI. The dominant component of
the plaque was determined by visual assessment. The sta-
tus of the fibrous cap was dichotomised into two groups:
thick and intact caps and thin or disrupted caps. A thick fi-
brous cap was characterised by a uniform dark band adja-
cent to the lumen on ToF images that showed strong en-
hancement on CE-T1WI and a smooth luminal surface on
all images. In thin fibrous caps, the dark band adjacent to
the lumen on ToF was missing and there was no enhance-
ment adjacent to the lumen on CE-T1WI, but a smooth lu-
minal surface on all images. The fibrous cap was consid-
ered ruptured when the dark band adjacent to the lumen
was missing or discontinuous on ToF images, the signal at
the site of the presumed rupture was hyperintense on ToF
images and the surface was irregular on the images of all
sequences.
Plaque resection
Carotid endarterectomy was performed using a standard
non-patch technique [18]. During surgery every effort was
made to completely resect the plaque in one piece. How-
ever, an incision longitudinally to the plaque is necessary
for removal. Therefore nonadherent fibrous cap / thrombus
may be altered during removal.
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Histological analysis
The histological analysis was carried out blinded to status
of the patients (symptomatic/asymptomatic) and the results
of the plaque analysis in MRI.
Carotid endarterectomy specimens were processed accord-
ing to standard protocols and histological slides were
stained with haematoxylin-eosin and Elastica-van-Gieson
stain.
For each specimen the following histological features were
assessed on haematoxylin-eosin-stained slides and classi-
fied as present or absent: calcification, LRNC (defined
by the presence of foamy macrophages and/or cholesterol
crystals), IPH (defined by the presence of haemosiderin
pigment or fresh haemorrhage deemed unrelated to the sur-
gical procedure), fibrous cap ulceration (defined by dis-
continuity in the fibrous cap with tissue reaction, namely
clotting and thrombus formation at the site of rupture). If
there was no indication of tissue reaction, the plaque was
considered intact. Continuity of the intima and atrophy of
the tunica media were assessed on Elastica-van-Gieson-
stained slides.
Comparison of plaque characteristics on MRI and his-
tology
We compared the following plaque morphology compo-
nents: calcification, LRNC, ulceration of the fibrous cap
and IPH. Congruence of MRI and the histopathological
correlates was analysed, as well as the prognostic value of
preoperative MR plaque imaging to estimate the vulnera-
bility of the carotid plaque. Plaque sections were not ex-
actly matched to slices in MRI, resulting, however, in an
absolute qualitative analysis of the whole plaque. We also
compared plaque morphology characteristics and baseline
factors between symptomatic and asymptomatic carotid
stenosis. IPH was reported if fresh or recent blood residues
were found. Older residues or chronic haemorrhage were
not included. The size of LRNC was estimated visually
both histologically and on MRI, and categorised as small
and large.
Statistical analysis
Continuous variables were expressed as mean ± 1 standard
deviation (SD) ranges. Detection statistics (sensitivity,
specificity) were evaluated and the chi-squared test for
contingency tables was used to compare nominal variables
(plaque components). A value of p <0.05 was considered
to indicate a significant difference. The diagnostic accura-
cy measures were calculated by percentage of agreement
and Cohen’s kappa (κ). Kappa was defined as fair from
0.21 to 0.40 and moderate from 0.41 to 0.60. The phi co-
efficient (φ) was used to show correlation of nominal vari-
ables. Correlation was assumed to be moderate if φ >0.3
and good if φ >0.5. Statistical analysis was performed by
using IBM SPSS Statistics software version 25.
Results
Demographic and baseline characteristics
In total 36 patients were included. Demographic and base-
line characteristics are summarised in tables 1 and 2. Mean
age (±SD) was 71.5 ± 8.68 years. Seven patients (19.4%)
were female. Twenty-five (69%) patients had a sympto-
matic ipsilateral carotid stenosis. A high-grade stenosis
was found in 28 patients (78%).
Plaque morphology components
Table 3 shows the comparison of the different plaque com-
ponents between histological and MRI analysis. LRNC
was found in 32 patients (89%) on histological and in 19
patients (52.8%) on MRI analysis. MRI showed a moder-
ate sensitivity (59%) and an excellent specificity (100%).
Cohen’s kappa showed fair but significant congruence (κ =
0.245, p = 0.025) between MRI and histological findings.
When we divided LRNC into subgroups of large versus
small lipid core, there was relatively low congruence be-
tween the two groups: fair but insignificant congruence for
large lipid cores (κ = 0.204, p = 0.201) and absolutely no
congruence (p = 1) for small lipid cores.
Table 1: Patient baseline characteristics.
Characteristic n (%)
Mean age ± standard deviation, years 71.5 ± 8.68
Women 7 (19.44%)
Vascular risk factors Arterial hypertension 23 (63.89%)
Smoking 12 (33.33%)
Diabetes mellitus 6 (16.67%)
Hypercholesterolaemia 28 (77.78%)
Coronary artery disease 5 (13.89%)
Atrial fibrillation 2 (5.56%)
Current medical treatment Antithrombotic treatment 31 (86.11%)
Oral anticoagulation therapy 2 (5.56%)
Antihypertensive treatment 26 (72.22%)
Statin therapy 30 (83.33%)
Table 2: Carotid stenosis characteristics.
Characteristics n (%)
Grade of carotid stenosis High (>70%) 28 (77.78%)
Moderate (50–69%) 8 (22.22%)
Symptomatic carotid stenosis 25 (69.44%)
Transient ischaemic attack 9 (25%)
Stroke 14 (38.88%)
Amaurosis fugax 2 (5.55%)
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Calcification was found in 89% in the histological analysis
and 75% on MRI. MRI showed moderate to high sensitivi-
ty (81.25%) and specificity (75%) in predicting plaque cal-
cification. Congruence was fair and statistically significant
(κ = 0.364, p = 0.013).
IPH appeared in 75% in histological analysis and in
52.78% on MRI. Sensitivity (62.96%) and specificity
(77.78%) of MRI analysis were moderate to high. A sig-
nificant fair correlation was found (κ = 0.314, p = 0.035).
There was a relatively low prevalence of ulceration of
the fibrous cap in histological analysis (27.78%), whereas
MRI showed disrupted plaque in 47.22%. Sensitivity
(50%) and specificity (53.85%) were poor and there was
no significant congruence between MRI and histology (κ =
0.032, p = 0.842).
Figure 1 shows a carotid plaque with LRNC and IPH in the
direct comparison of MRI and histological analysis in the
same patient.
Plaque morphology components in symptomatic and
asymptomatic carotid stenosis
We made the same accuracy tests in subgroups of patients
with symptomatic carotid stenosis (n = 25) and patients
without neurological symptoms (n = 11). Detailed results
are shown in tables 4 and 5.
There was the same trend as in the total study population,
with significant and even higher levels of congruence for
LRNC (κ = 0.390, p = 0.014) and IPH (κ = 0.386, p =
0.045). For calcification, slightly lower congruence was
found (κ = 0.339), which was close to significant (p =
0.065).
In the asymptomatic subgroup calcification showed mod-
erate (κ = 0.421) but not significant congruence (p =
0.087). The remaining plaque components did not show
any significant results or trends.
Correlation of plaque morphology with the presence of
neurological symptoms
When comparing plaque morphology characteristics with
the presence of cerebral ischaemic symptoms, we found
significant correlation (p = 0.042) for the plaque morphol-
ogy feature of LRNC on MRI. Tables 6 and 7 show de-
tailed results of both MRI and histology. LRNC was found
more frequently on MRI in symptomatic patients (n = 16,
64%) than asymptomatic patients (n = 3, 27.3%). Phi co-
efficient (φ) showed moderate but significant correlation
(φ = 0.339, p = 0.042). The division into large and small
LRNC did not result in significant correlation.
When the other plaque morphology features (ulceration,
IPH and calcification) were compared with neurological
symptoms, no sufficient significance could be proved for
either MRI or histology. However, ulceration was more of-
ten seen on MRI in symptomatic patients (n = 14, 56% of
symptomatic patients) than in asymptomatic (n = 3, 27.3%
of asymptomatic patients) although with no statistically
significance (p = 0.112).
Histological analysis did not show significant correlation
between any of the vulnerability criteria (LRNC, IPH, ul-
cerated fibrous cap) and cerebral ischaemic symptoms.
Discussion
The main findings in this comparison of qualitative plaque
analysis on MRI with histological analysis as the reference
standard were statistically significant agreements between
plaque calcification, LRNC and IPH. With significant re-
sults in three of the four plaque features examined, this
study shows a relatively good accuracy of MRI in detect-
ing carotid plaque components.
Plaque vulnerability
For assessing the vulnerability of a carotid plaque, the in-
traplaque components prone to rupture are of great inter-
est. IPH and a large LRNC are known risk factors for
plaque ulceration [12, 13], whereas plaque calcification
is associated with plaque stability [14]. Various studies
focused on the correlation of carotid plaque components
and the presence of cerebral ischaemic symptoms. Com-
plex atherosclerotic carotid plaques (type VI in the modi-
fied American Heart Association [AHA] classification by
Naghavi [19]) with a large lipid core, thin or ruptured
surface, haemorrhage or thrombus formation were shown
to be more common in patients with symptomatic carotid
stenosis [20, 21]. Several studies showed that a ruptured fi-
brous cap detected by MRI was associated with recent his-
tory of stroke or transient ischaemic attack [22, 23]. Ulcer-
ation was also more frequently found in the symptomatic
cohort of our patients (56 vs 27%). However, congruency
between MRI and histological findings was not significant
for ulceration (p = 0.112). This may be explained by our
stricter definition of an ulcerated fibrous cap, whereby we
assumed a state of ulceration only if the plaque showed tis-
sue reaction (thrombus formation) in the histological sec-
tions.
Retrospective [24] and prospective [25] studies showed
a strong correlation between IPH and cerebral ischaemic
symptoms. In our analysis we could prove that LRNC
was significantly more frequent in plaques of patients with
Table 3: Plaque morphology components and congruency between histology and MRI (n = 36).
Prevalence histol-
ogy
n (%)
Prevalence MRI
n (%)
Sensitivity
(%)
Specificity (%) Significance*
(p-value)
% agreement Cohen’s
κ
LRNC† Total 32 (88.89%) 19 (52.78%) 59.39% 100% 0.025 63.89% 0.245
Large‡ 14 (38.88%) 11 (30.56%) 46.86% 77.27% 0.201 63.89% 0.204
Small 18 (50.00%) 8 (22.22%) 22.22% 77.78% 1.000 52.78% 0.031
Calcification† 32 (88.89%) 27 (75.00%) 81.25% 75.00% 0.013 80.56% 0.364
IPH† 27 (75.00%) 19 (52.78%) 62.96% 77.78% 0.035 66.67% 0.314
Ulceration† 10 (27.78%) 17 (47.22%) 50.00% 53.85% 0.842 55.78% 0.032
IPH = intraplaque haemorrhage; LRNC = lipid-rich necrotic core; MRI = magnetic resonance imaging 95% confidence interval: sensitivity 38.07–69.49; specificity: 65.24–88.65 *
p-value refers to Cohen’s κ. † plaque components were identified and quantified visually in both analyses. ‡ size of lipid cores was estimated surface. Large LRNC was defined
as continuous lipid core being the predominant aspect of the plaque.
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Figure 1: MRI appearance of a vulnerable internal carotid artery (ICA) plaque with lipid-rich necrotic core (LRNC) and intraplaque haemor-
rhage (IPH) (1 to 3) and the histological correlate (a, b) in the same patient. T1-weighted precontrast, non-fat-suppressed image showing a
predominantly hyperintense plaque, vessel lumen marked with L (1), T2-weighted (2) and post-gadolinium T1, fat-suppressed sequences (3)
showing partial suppression of the plaque signal at the anterior aspect of the plaque suggesting that this is the lipid-rich part of the plaque (red
area), while the rest of the plaque, which remains hyperintense in all sequences represents the intraplaque haemorrhage (blue area). ICA with
lipid core and broken fibrous cap. In between intraplaque haemorrhage (blue area) (a). Typical crystalloid shape of washed out lipid collections
in the lipid rich necrotic core of the plaque, marked with arrows (b).
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cerebral ischaemic symptoms (64 in symptomatic vs 27%
in asymptomatic patients, p = 0.042). These findings are
in line with different studies where LRNC was associated
with symptomatic carotid stenosis and ipsilateral stroke
[16, 26]. A large study comparing stable and vulnerable
plaques, according to the AHA criteria, also showed a
significantly higher lipid content (LRNC) in vulnerable
plaques [27]. A significant correlation between IPH and
cerebral symptoms, even though IPH is described as one
of the compositional characteristics of vulnerable plaques
[28, 29], could not be proved in our analysis. It is not en-
tirely clear why histological findings, defined as the gold
standard, did not show a correlation to ischaemic symp-
toms despite there being quite good congruence of plaque
components between MRI and histology. This discrepancy
might be partially explained by lack of congruence on the
presence of ulceration – a component that is strongly asso-
ciated to plaque vulnerability.
Plaque composition
Other studies with histological validation determined that
multi-contrast high-resolution-MRI can characterise
plaque morphology [30], as well as plaque components
such as LRNC, IPH, calcification and the fibrous cap [31].
More recently, Xia et al. showed that multi-contrast high-
resolution MRI (3.0 Tesla) has a high accuracy in detection
Table 4: Plaque morphology components and congruency between histology and MRI in symptomatic patients (n = 25).
Prevalence histol-
ogy
n (%)
Prevalence MRI
n (%)
Sensitivity
(%)
Specificity (%) Significance*
(p-value)
% agreement Cohen’s
κ
LRNC Total 22 (88%) 16 (64%) 72.73% 100% 0.014 76.00% 0.390
Large 11 (44%) 9 (36%) 45.45% 71.43% 0.383 60.00% 0.172
Small 11 (44%) 7 (28%) 27.27% 71.43% 0.943 52.00% −0.013
Calcification 22 (88%) 19 (76%) 81.82% 66.67% 0.065 80.00% 0.339
IPH 18 (72%) 15 (60%) 72.22% 71.43% 0.045 72.00% 0.386
Ulceration 7 (28%) 14 (56%) 57.14% 44.44% 0.94 48.00% 0.012
IPH = intraplaque haemorrhage; LRNC = lipid-rich necrotic core; MRI = magnetic resonance imaging 95% confidence interval: sensitivity 43.13–75.75; specificity: 56.74–85.06 *
p-value refers to Cohen’s κ.
Table 5: Plaque morphology components and congruency between histology and MRI in asymptomatic patients (n = 11)
Prevalence histol-
ogy
n (%)
Prevalence MRI
n (%)
Sensitivity
(%)
Specificity (%) Significance*
(p-value)
% agreement Cohen’s
κ
LRNC Total 10 (90.91%) 3 (27.27%) 30.00% 100% 0.521 36.36% 0.072
Large 3 (27.27%) 2 (18.18%) 33.33% 87.50% 0.425 72.73% 0.233
Small 7 (63.64%) 1 (9.09%) 14.29% 100% 0.428 45.45% 0.108
Calcification 10 (90.91%) 8 (72.73%) 80.00% 100% 0.087 81.82% 0.421
IPH 9 (81.81%) 4 (36.36%) 44.44% 100% 0.237 54.55% 0.225
Ulceration 3 (27.27%) 3 (27.27%) 33.33% 75.00% 0.782 63.64% 0.083
IPH = intraplaque haemorrhage; LRNC = lipid-rich necrotic core; MRI = magnetic resonance imaging 95% confidence interval: sensitivity 21.46–57.00; specificity 85.38–100.00 *
p-value refers to Cohen’s κ.
Table 6: Correlation between plaque components in MRI and neurological symptoms (n = 36).
Prevalence symp-
toms
n (%)
Prevalence compo-
nent
n (%)
Sensitivity
(%)
Specificity
(%)
Correlation
(φ)
Significance*
(p-value)
LRNC Total 19 (52.78%) 16 (44.44%) 66.67% 25.00% 0.339 0.042
Large 11 (30.56%) 9 (25.00%) 81.82% 36.00% 0.178 0.285
Small 8 (22.22%) 7 (19.44%) 87.50% 35.71% 0.210 0.209
Calcification 27 (75.00%) 19 (52.80%) 70.37% 33.33% 0.035 0.835
IPH 19 (52.78%) 15 (41.67%) 78.95% 41.18% 0.218 0.191
Ulceration 17 (47.2%) 14 (39.9%) 82.35% 42.11% 0.265 0.112
IPH = intraplaque haemorrhage; LRNC = lipid-rich necrotic core; MRI = magnetic resonance imaging 95% confidence interval: sensitivity 71.63–84.26; specificity 30.61–40.50 *
p-value refers to correlation.
Table 7: Correlation between plaque components in histology and neurological symptoms (n = 36).
Prevalence symptoms
n (%)
Prevalence compo-
nent
n (%)
Sensitivity
(%)
Specificity
(%)
Correlation
(φ)
Significance*
(p-value)
LRNC Total 32 (88.89%) 22 (61.11%) 66.67% 25.00% -0.043 0.798
Large 13 (36.11%) 10 (27.78%) 76.92% 34.78% 0.122 0.464
Small 18 (50.00%) 11 (30.56%) 61.11% 22.22% -0.181 0.278
Calcification 32 (88.89%) 10 (27.78%) 66.67% 25.00% -0.043 0.798
IPH 27 (75.00%) 18 (50.00%) 66.67% 22.22% -0.104 0.531
Ulceration 10 (27.78%) 7 (19.44%) 70.00% 30.77% 0.007 0.964
IPH = intraplaque haemorrhage; LRNC = lipid-rich necrotic core; MRI = magnetic resonance imaging 95% confidence interval: sensitivity 63.83–72.19; specificity 22.62–30.71 *
p-value refers to correlation.
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of common plaque components, in a larger study popula-
tion (n = 817) [27].
In the analysis of studies comparing of in-vivo MRI with
histological examination as the gold standard, it is nec-
essary to distinguish between qualitative and quantitative
analysis. Saam et al. [31] evaluated 31 MRI subjects by
a quantitative analysis (four histological sections of 0.5
mm were matched to one MR slice of 2 mm) and found
good to strong correlation of LRNC, IPH and calcifications
(Pearson’s coefficient from 0.66 for IPH to 0.75 for LRNC,
all with p <0.001). Our correlation was not as strong but
showed the same trend: Calcification (κ = 0.364, p =
0.013), LRNC (κ = 0.245, p = 0.025) and IPH (κ = 0.314, p
= 0.035) showed stronger correlation than the status of the
fibrous cap.
Study limitations
One limitation of this study was the relatively small patient
cohort (n = 36). Furthermore, our analysis was simply
qualitative, which meant that for histological analysis sec-
tions with the most representative presence of plaque com-
ponents were chosen and accorded to MRI. However, the
quality of our analysis can be considered as good, because
the histological reprocessing of the whole plaque ended in
a selection of the most significant sections.
Conclusions
At our centre, high-resolution preoperative MRI can iden-
tify plaque components with adequate safety in sympto-
matic and asymptomatic carotid stenosis. Plaque charac-
teristics detected on MRI may therefore be used for risk
stratification of ipsilateral stroke for patients with carotid
artery plaque, especially in asymptomatic patients and
symptomatic patients with low- to moderate-degree steno-
sis. LRNC seems to be a useful marker of plaque vul-
nerability and its use in clinical decision making is war-
ranted. Further research, especially in larger multicentre
trials is needed to prove the accuracy of MRI in detecting
carotid plaque components for clinical use. Furthermore, it
will be interesting to follow the use of new post-process-
ing imaging techniques, such as quantitative susceptibili-
ty mapping or diffusion-weighted imaging, in analysis of
carotid plaque components.
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